Yasunobu Kai
Director/Miembro de la Junta en H3 Biomedicine, Inc. .
Cargos activos de Yasunobu Kai
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
H3 Biomedicine, Inc.
 H3 Biomedicine, Inc. Pharmaceuticals: MajorHealth Technology Part of Eisai Co., Ltd., H3 Biomedicine, Inc. is a precision oncology research and development subsidiary based in Cambridge, MA. The company is uniquely positioned to integrate real-world clinical evidence with the latest advances in cancer genomics. H3 is developing a pipeline of highly targeted, breakthrough medicines that have the potential to impact the future of cancer care and treatment. The CEO of the company is Takashi Owa. | Director/Miembro de la Junta | - | - |
Historial de carrera de Yasunobu Kai
Antiguos cargos conocidos de Yasunobu Kai.
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| EISAI CO., LTD. | Corporate Officer/Principal | 01/04/1986 | - |
Estadísticas
Internacional
| Japón | 2 |
| Estados Unidos | 2 |
Operativa
| Corporate Officer/Principal | 1 |
| Director/Board Member | 1 |
Sectorial
| Health Technology | 3 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| EISAI CO., LTD. | Health Technology |
| Empresas privadas | 1 |
|---|---|
H3 Biomedicine, Inc.
H3 Biomedicine, Inc. Pharmaceuticals: MajorHealth Technology Part of Eisai Co., Ltd., H3 Biomedicine, Inc. is a precision oncology research and development subsidiary based in Cambridge, MA. The company is uniquely positioned to integrate real-world clinical evidence with the latest advances in cancer genomics. H3 is developing a pipeline of highly targeted, breakthrough medicines that have the potential to impact the future of cancer care and treatment. The CEO of the company is Takashi Owa. | Health Technology |
- Bolsa de valores
- Insiders
- Yasunobu Kai
- Experiencia
